Novavax (NVAX) Stock Leaps As Settlement Spurs Investor Optimism

The stock value of Novavax, Inc (NASDAQ: NVAX) had a significant increase of 22.61% in the last session, ending at $4.88. The completion of a settlement agreement led to this rise in Novavax’s stock price. The cooperation between Gavi, the Vaccine Alliance, and Novavax (NVAX) has paid off as the parties have reported that issues […]

Investors Are Once Again Showing Interest In Vaccine Stocks

Once again, pharmaceutical companies related to Covid-19 vaccines have been quite closely related. Novavax Inc. (NVAX) leapt by +2.93% to $120.27 on Tuesday. The U.S. biotechnology firm’s latest coronavirus vaccine candidate could be accepted next year, subject, of course, to good outcomes from the recently completed Phase 3 clinical trial. Pfizer Inc. (PFE) was up […]